000 | 01496 a2200433 4500 | ||
---|---|---|---|
005 | 20250513160515.0 | ||
264 | 0 | _c19990125 | |
008 | 199901s 0 0 eng d | ||
022 | _a0960-894X | ||
024 | 7 |
_a10.1016/s0960-894x(98)00158-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEgron, D | |
245 | 0 | 0 |
_aAnti-HIV pronucleotides: decomposition pathways and correlation with biological activities. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry letters _cMay 1998 |
||
300 |
_a1045-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-HIV Agents _xchemistry |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aHIV-1 _xdrug effects |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndicators and Reagents |
650 | 0 | 4 |
_aProdrugs _xchemical synthesis |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aThymidine Kinase _xdeficiency |
650 | 0 | 4 |
_aVirus Replication _xdrug effects |
650 | 0 | 4 |
_aZidovudine _xanalogs & derivatives |
700 | 1 | _aLefebvre, I | |
700 | 1 | _aPérigaud, C | |
700 | 1 | _aBeltran, T | |
700 | 1 | _aPompon, A | |
700 | 1 | _aGosselin, G | |
700 | 1 | _aAubertin, A M | |
700 | 1 | _aImbach, J L | |
773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 8 _gno. 9 _gp. 1045-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0960-894x(98)00158-9 _zAvailable from publisher's website |
999 |
_c9834129 _d9834129 |